Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Détails

Ressource 1Télécharger: 39463445.pdf (436.40 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_53683E948F54
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
UNIL/CHUV
Titre
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Périodique
Swiss medical weekly
Auteur⸱e⸱s
Arber C., Baerlocher G., Chalandon Y., Daskalakis M., Duchosal M., Fehr M., Gerull S., Güngör T., Nair G., Pabst T., Passweg J.R., Piccolruaz B., Renner C., Ruefer A., Schneidawind D., Stüssi G., Zeerleder S., Halter J.P.
Collaborateur⸱rice⸱s
Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
03/10/2024
Peer-reviewed
Oui
Volume
154
Pages
3704
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
URN
urn:nbn:ch:serval-BIB_53683E948F540
OAI-PMH
oai:serval.unil.ch:BIB_53683E948F54
DOI
10.57187/s.3704
Pubmed
39463445
Web of science
001342318400009
Open Access
Oui
Création de la notice
01/11/2024 15:23
Dernière modification de la notice
20/12/2024 7:07
Données d'usage